Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT

Clinical trial NCT07764978 · RECRUITING

Trial details

NCT number: NCT07764978
Sponsor: AstraZeneca
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Newly Diagnosed Multiple Myeloma

Start date: 2026-06-26
Primary completion: 2029-01-11
Enrollment: 750

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.